Response to Comment on Gregory et al. COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 1 and Type 2 Diabetes. Diabetes Care 2021;44:526-532.

We thank Maahs et al. for their insightful comments (1) regarding our prospective cohort study quantifying the impact of coronavirus disease 2019 (COVID-19) in patients with diabetes (2). We are pleased to learn no death or mechanical ventilation related to COVID-19 in pediatrics has been reported to the T1D Exchange registry to date. Death and mechanical ventilation are fortunately rare events in all of pediatrics, however. For this reason, comparing the odds of hospitalization or a greater severity of illness against a matched control group may better quantify excess COVID-19 risk in pediatric diabetes and guide policy. Our initial report analyzed COVID-19 cases identified through 7 August 2020. Since then, our patient accrual has grown from 6,138 to 21,929 with no diabetes, 40 to 160 with type …